Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P2.06 - Mesothelioma (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 41
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.06-23 - Association of Two BRM Promoter Polymorphisms and Tobacco Exposure with Malignant Pleural Mesothelioma (MPM) Risk and Survival
16:45 - 18:00 | Presenter: Min Joon Lee
- Abstract
Loading...
-
+
P2.15 - Treatment in the Real World - Support, Survivorship, Systems Research (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 33
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.15-10 - Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer.
16:45 - 18:00 | Presenter: Badr Id Said
- Abstract
Loading...
-
+
MA23 - Early Stage Lung Cancer: Present and Future
- Type: Mini Oral Abstract Session
- Track: Treatment of Early Stage/Localized Disease
- Presentations: 12
- Coordinates: 9/26/2018, 10:30 - 12:00, Room 105
-
+
MA23.07 - Defining the Role of Adjuvant Therapy for Early Stage Large Cell Neuroendocrine Lung Cancer
11:10 - 11:15 | Presenter: Elliot Wakeam
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.03 - Biology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 30
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.03-29 - The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Hadas Sorotsky
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 29
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.04-20 - Correlation of Immune-Related Adverse Events and Response from Immune Checkpoint Inhibitors in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Mike Sung
- Abstract
Loading...
-
+
P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 47
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.16-07 - The Impact of Clinical and Molecular Profile of Resected EGFR-Mutant Non-Small Cell Lung Cancer on the Risk of Developing Brain Metastases
12:00 - 13:30 | Presenter: Mor Moskovitz
- Abstract
Loading...
-
+
MA25 - Oligometastasis: Defining, Treating, and Evaluating
- Type: Mini Oral Abstract Session
- Track: Oligometastatic NSCLC
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 203 BD
-
+
MA25.11 - Clinical and Molecular Predictors of Outcome in Patients with EGFR mutant NSCLC Brain Metastases treated with RT
14:40 - 14:45 | Presenter: Fabio Y Moraes
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA27 - Novel Drugs and PDX Models
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
- Presentations: 12
- Coordinates: 9/26/2018, 13:30 - 15:00, Room 206 BD
-
+
MA27.03 - Multi-Omic Characterization of TKI-Treated Drug-Tolerant Cell Population in an EGFR-Mutated NSCLC Primary-Derived Xenograft
13:40 - 13:45 | Presenter: Erin L Stewart
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev